2 news items
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
ABBV
CI
CVS
7 Jun 24
. over the past year, Reuters reports.
This raises concerns among drug pricing experts and analysts about the sustainability
UnitedHealth's OptumRx Unveils New Transparent Drug Pricing Initiative for 2024
CAH
CVS
UNH
21 May 24
aims to provide a more transparent and predictable drug pricing structure. It addresses the complexities and ambiguities in the current system
- Prev
- 1
- Next